蛋白质组学分析鉴定CLEC4C表达为心脏移植后原发性移植物功能障碍的新型生物标志物
本研究在219例成人心脏移植受者中,于移植前采集血清进行Olink蛋白质组学检测(354种蛋白),随机分为推导集(n=131)和验证集(n=88),以改良ISHLT标准定义原发性移植物功能障碍(PGD)。推导集发现9种蛋白与PGD相关,验证集中仅CLEC4C经Bonferroni校正后仍显著相关(OR=3.04,95%CI 1.74-5.82,p=2.8×10⁻⁴),且CLEC4C单独或联合临床协变量可提高对PGD的判别能力。
要点
- 移植前循环CLEC4C水平与心脏移植后PGD风险独立相关。
- CLEC4C联合临床协变量对PGD的判别AUC为0.69,优于RADIAL评分(AUC=0.55)。
- 干扰素-α反应和C型凝集素信号通路在PGD中显著富集。
核心结论
- 移植前循环CLEC4C水平可能识别心脏移植后PGD高风险受者。
- 浆细胞样树突状细胞(pDC)及先天免疫反应在PGD中的潜在作用需进一步研究。
研究设计与样本
- 研究纳入2016年至2020年杜克大学医学中心219例成人心脏移植受者,随机分为推导集(n=131)和验证集(n=88)。
- 采用改良ISHLT标准定义PGD,使用Olink panel(354种蛋白)检测移植前血清样本。
- 采用单变量和多变量模型(受者年龄、肌酐、机械循环支持、性别;供者年龄;缺血时间)分析蛋白表达与PGD的关联。
主要发现
- 推导集单变量模型中9种蛋白与PGD相关。
- 验证集中仅CLEC4C经Bonferroni校正后仍与PGD相关(OR=3.04,95%CI 1.74-5.82,p=2.8×10⁻⁴)。
- CLEC4C的关联模式在双心室/左心室和孤立性右心室PGD亚组中一致。
- 通路分析显示干扰素-α反应和C型凝集素信号通路显著富集。
- RADIAL评分对PGD预测能力差(AUC=0.55);CLEC4C单独(AUC=0.66,p=0.048)及联合多变量模型临床协变量(AUC=0.69,p=0.018)改善对主要结局的判别。
关键数值与推荐
- PGD定义采用改良ISHLT标准。
- CLEC4C与PGD关联的OR=3.04(95%CI 1.74-5.82),p=2.8×10⁻⁴。
- RADIAL评分预测PGD的AUC=0.55;CLEC4C单独AUC=0.66(p=0.048);CLEC4C联合临床协变量AUC=0.69(p=0.018)。
临床怎么用
- 移植前检测循环CLEC4C水平可能有助于识别PGD高风险受者。
- CLEC4C联合临床协变量可改善对PGD的判别能力,优于RADIAL评分。
局限性
- 研究为单中心回顾性设计,样本量有限。
- CLEC4C对PGD的预测判别能力中等(AUC=0.69)。
- pDC及先天免疫反应在PGD中的具体机制尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Clinical models to identify patients at high risk of primary graft dysfunction (PGD) after heart transplantation (HT) are limited, and the underlying pathophysiology of this common post-transplant complication remains poorly understood. We sought to identify whether pre-transplant levels of circulating proteins reporting on immune activation and inflammation are associated with incident PGD. METHODS: The study population consisted of 219 adult heart transplant recipients identified between 2016 and 2020 at Duke University Medical Center, randomly divided into derivation (n = 131) and validation (n = 88) sets. PGD was defined using modified ISHLT criteria. Proteomic profiling was performed using Olink panels (n = 354 proteins) with serum samples collected immediately prior to transplantation. Association between normalized relative protein expression and PGD was tested using univariate and multivariable (recipient age, creatinine, mechanical circulatory support, and sex; donor age; ischemic time) models. Significant proteins identified in the derivation set (p < 0.05 in univariate models), were then tested in the validation set. Pathway enrichment analysis was used to test candidate biological processes. The predictive performance of proteins was compared to that of the RADIAL score. RESULTS: Nine proteins were associated with PGD in univariate models in the derivation set. Of these, only CLEC4C remained associated with PGD in the validation set after Bonferroni correction (OR [95% CI] = 3.04 [1.74,5.82], p = 2.8 × 10-4). Patterns of association were consistent for CLEC4C in analyses stratified by biventricular/left ventricular and isolated right ventricular PGD. Pathway analysis identified interferon-alpha response and C-type lectin signaling as significantly enriched biologic processes. The RADIAL score was a poor predictor of PGD (AUC = 0.55). CLEC4C alone (AUC = 0.66, p = 0.048) and in combination with the clinical covariates from the multivariable model (AUC = 0.69, p = 0.018) improved discrimination for the primary outcome. CONCLUSIONS: Pre-transplantation circulating levels of CLEC4C, a protein marker of plasmacytoid dendritic cells (pDCs), may identify HT recipients at risk for PGD. Further studies are needed to better understand the potential role pDCs and the innate immune response in PGD.
引用
- Truby LK, Kwee LC, Agarwal R, et al. Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation. J Heart Lung Transplant. 2021. PMID: 34511330. doi:10.1016/j.healun.2021.07.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。